EP-9001A
/ Easton Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 04, 2022
a Safety and Tolerability Study of EP-9001A in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=44 | Recruiting | Sponsor: Chengdu Easton Biopharmaceuticals Co,Ltd | Not yet recruiting ➔ Recruiting
Enrollment open
March 14, 2022
Phase I Trial of EP-9001A in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=44 | Not yet recruiting | Sponsor: Chengdu Easton Biopharmaceuticals Co,Ltd
New P1 trial
1 to 2
Of
2
Go to page
1